Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor
Navigation Menu

Type(s) of colorectal cancer (CRC)-Adenocarcinoma of the colon Posts on Medivizor

Can CEA levels predict tumor response to treatment in advanced colorectal cancer?

Posted by on Feb 12, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the relationship between changes in the levels of carcinoembryonic antigen (CEA) and colorectal cancer response to treatment. Researchers suggested that CEA levels are associated with tumor response and can be used as a prognostic factor. Some background In 2014 the European Society for Medical Oncology...

Read More

Regorafenib followed by cetuximab is associated with longer survival in the treatment of advanced colorectal cancer

Posted by on Jan 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of treatment with regorafenib (Stivarga) followed by cetuximab (Erbitux) in the treatment of advanced colorectal cancer. Researchers suggested that this treatment improves survival of these patients. Some background New treatments have become available in the past 20 years to treat...

Read More

Thyroid hormones ratio can predict outcomes in patients with advanced colorectal cancer

Posted by on Dec 8, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of the thyroid hormones (TH) on survival outcomes of patients with colorectal cancer treated with regorafenib (Stivarga). Researchers suggested that TH ratio can predict the outcomes in these patients. Some background TH such as FT3 (free triiodothyronine) and FT4 (free thyroxine) are released...

Read More

Predictive factors for the treatment of metastatic colorectal cancer with panitumumab

Posted by on Dec 5, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of panitumumab (Vectibix) and the predictive factors for the treatment of metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that this treatment was effective for these patients and that early tumor shrinkage and RAS mutation (permanent change) are...

Read More

PET-CT scanning in the early detection of metastasis in patients with colon cancer

Posted by on Nov 25, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the positive effect of PET-CT (an imaging technique) evaluation after surgery in stage 3 colon cancer. Researchers suggested that early follow-up with PET-CT leads to early detection of metastasis (spread to other parts of the body) in patients with stage 3 colon cancer. Some background Stage 3 colon cancer...

Read More

Oral mucositis caused by targeted therapy for colorectal cancer: which drug is safer?

Posted by on Nov 4, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the frequency and severity of oral mucositis (OM) in patients with colorectal cancer treated with chemotherapy and panitumumab (Vectibix) or cetuximab (Erbitux). Researchers suggested that panitumumab ?is associated with increased levels of OM in these patients. Some background Colorectal cancer is the fourth...

Read More

Radiotherapy improves cancer outcomes in patients with advanced colorectal cancer

Posted by on Oct 27, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of radiotherapy in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that radiotherapy could be a safe option for the treatment of these patients. Some background Colorectal cancer is the third most frequently diagnosed cancer....

Read More

Evaluating Cetuximab plus FOLFOX-4 chemotherapy for patients with metastatic colorectal cancer

Posted by on Oct 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of cetuximab (Erbitux) combined with FOLFOX-4 (leucovorin, fluorouracil, and oxaliplatin) chemotherapy to treat metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment is associated with improved cancer outcomes. Some background...

Read More

Surgery improves survival of colorectal cancer patients with lung metastasis

Posted by on Aug 17, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of surgery to lung metastasis (LM; cancer spreads to the lungs) in patients with colorectal cancer. Researchers suggested that lung surgery increases the survival of these patients.   Some background Colorectal cancer is one of the major diseases seen in the US. LM appear in 5-15% of patients and...

Read More

Accurate diagnosis and treatment of diarrhea following colon cancer surgery can improve quality of life

Posted by on Jul 14, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the causes and treatment options for diarrhea after colon surgery in colon cancer patients. Researchers suggested that an accurate diagnosis will improve the treatment of these patients. Some background Surgery to remove colon tumors changes the anatomy and the normal intestinal function of the bowel. Thus, many...

Read More

mFOLFOX6 and XELOX have similar side effect rates stage 3 colon cancer

Posted by on Jun 27, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety of the chemotherapies mFOLFOX6 and XELOX in Japanese colon cancer patients. Researchers suggested that the safety of both treatments is acceptable. Some background FOLFOX chemotherapy is the standard treatment for stage 3 colon cancer patients who underwent surgery. mFOLFOX6 combines leucovorin,...

Read More